Role of the beta3 integrin subunit in human primary melanoma progression: multifunctional activities associated with alpha(v)beta3 integrin expression.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Design, Synthesis and Anti-Melanoma Activity of Novel Annexin V Derivative with βInternational journal of molecular sciences · 2023
   Article
2. Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead.Cells · 2021
   Review
3. Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.Oncotarget · 2016
   Article
4. Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.The FEBS journal · 2013
   Review
5. Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy.Theranostics · 2013
   Article
6. siRNA-mediated silencing of integrin β3 expression inhibits the metastatic potential of B16 melanoma cells.Oncology reports · 2012
   Article
7. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.Diagnostic pathology · 2012
   Article
8. Characterization of a new human melanoma cell line with CD133 expression.Human cell · 2012
   Article
9. RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating α(v)β₃ expression.International journal of nanomedicine · 2012
   Article
10. Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?Molecular oncology · 2011
    Review
11. Stress as a possible mechanism in melanoma progression.Dermatology research and practice · 2010
    Article
12. Anatomical and molecular imaging of skin cancer.Clinical, cosmetic and investigational dermatology · 2008
    Article
13. Angiogenesis in melanoma.Seminars in oncology · 2007
    Review
14. PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells.Oncogene · 2006
    Article
15. Expression of ADAM15 in lung carcinomas.Virchows Archiv : an international journal of pathology · 2005
    Article
16. Role of PLZF in melanoma progression.Oncogene · 2004
    Article
17. beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.Molecular and cellular biology · 2001
    Article

Corrections and comments

• Comment on
  Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma.1998

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as